According to AEON Biopharma's latest financial reports the company has $16.17 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $9.74 M | 90.05% |
2021-12-31 | $5.12 M | -74.57% |
2020-12-31 | $20.16 M | -81.95% |
2019-12-31 | $0.11 B |